Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers.

Microspheres were prepared from poly(L-lactic acid) polymers having molecular weights between 500 and 50k g/mol. The polymers were synthesized using two initiator molecules, L-lactic acid oligomer (PLLA-LA) or stearyl alcohol (PLLA-SA). For both PLLA-LA and PLLA-SA polymers, glass (Tg) and melting (Tm) transition temperatures and enthalpy of melting all increased as the polymer molecular weight increased. PLLA-SA showed the greatest change in Tg (-13 to 54 degrees C) as molecular weight increased from 500 to 10k x g/mol, compared to 25 to 55 degrees C for PLLA-LA polymers. Changes in Tm and enthalpy of melting with increasing molecular weight were similar for both PLLA-LA and PLLA-SA. Paclitaxel release from 30% paclitaxel loaded microspheres in the size range of 50-90 microm was affected by these changes in polymer properties as molecular weight increased. As the molecular weight increased from 2k to 50k x g/mol the amount of drug released from microspheres over 14 days decreased from 76 to 11% of the initial drug load. The release profiles were consistent with a diffusion controlled mechanism provided a two-compartment model was employed. According to this model, the total amount of 'available' drug (compartment 1) was released by diffusion in 14 days while the remainder (compartment 2) was confined within the polymeric matrix and could not diffuse out at a measurable rate. Following the in vitro release study, microsphere made from 2k-10k g/mol polymers showed significant signs of disintegration whereas 50k x g/mol polymer microspheres remained intact.

[1]  J. Kohn,et al.  Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. , 1991, Biomaterials.

[2]  W. Hunter,et al.  Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). , 1995, Cancer letters.

[3]  R. Mumper,et al.  Poly(L-lactic Acid) Microspheres Containing Neutron-Activatable Holmium-165: A Study of the Physical Characteristics of Microspheres Before and After Irradiation in a Nuclear Reactor , 2004, Pharmaceutical Research.

[4]  J. C. Price,et al.  Control of Drug Release Rate by Use of Mixtures of Polycaprolactone and Cellulose Acetate Butyrate Polymers , 1987 .

[5]  Toguchi Hajime,et al.  Factors influencing the profiles of TRH release from copoly(d,l-lactic/glycolic acid) microspheres , 1991 .

[6]  J. Dressman,et al.  SOME DETERMINANTS OF MORPHOLOGY AND RELEASE RATE FROM POLY(L)LACTIC ACID MICROSPHERES , 1990 .

[7]  R. Liggins,et al.  Paclitaxel loaded poly(L-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill. , 2000, Biomaterials.

[8]  P. Flandroy,et al.  Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materials , 1996 .

[9]  W L Hunter,et al.  The development of a novel intraperitoneal tumor-seeding prophylactic. , 1997, American journal of surgery.

[10]  R. Jalil,et al.  Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone. , 1990, Journal of microencapsulation.

[11]  W L Hunter,et al.  Solid-state characterization of paclitaxel. , 1997, Journal of pharmaceutical sciences.

[12]  H. Sato,et al.  Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. , 1996, Chemical & pharmaceutical bulletin.

[13]  W. Bragg,et al.  The Crystalline State , 1925 .

[14]  H. Leaderman,et al.  Physical properties of polymers , 1962 .

[15]  P. Rohdewald,et al.  A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents , 1990 .

[16]  H. Yamanaka,et al.  In vivo controlled release of a luteinizing hormone-releasing hormone agonist from poly(dl-lactic acid) formulations of varying degradation pattern , 1991 .

[17]  Yoshito Ikada,et al.  Thermal characterization of polylactides , 1988 .

[18]  Ross R. Muth,et al.  Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .

[19]  Y. Ikada,et al.  Controlled cisplatin delivery system using poly(D,L-lactic acid). , 1992, Biomaterials.

[20]  A. Schindler,et al.  Polylactide. II. Viscosity–molecular weight relationships and unperturbed chain dimensions , 1979 .

[21]  A. Schindler,et al.  Aliphatic Polyesters. III. Molecular Weight and Molecular Weight Distribution in Alcohol- Initiated Polymerizations of e-Caprolactone , 1982 .

[22]  J. Mcginity,et al.  The Influence of Polymer Glass Transition Temperature and Molecular Weight on Drug Release from Tablets Containing Poly(DL-lactic Acid) , 2004, Pharmaceutical Research.

[23]  D. Grijpma,et al.  Synthesis and hydrolytic degradation behaviour of high-molecular-weight l-lactide and glycolide copolymers , 1990 .

[24]  Hitoshi Sato,et al.  In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres , 1997 .

[25]  T. Hogan,et al.  Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. , 1986, Journal of microencapsulation.

[26]  M. Scandola,et al.  Thermal properties and physical ageing of poly (l-lactic acid) , 1992 .

[27]  Richard W. Baker,et al.  Controlled Release of Biologically Active Agents , 1987 .

[28]  F. N. Kelley,et al.  Viscosity and glass temperature relations for polymer‐diluent systems , 1961 .

[29]  R. Bodmeier,et al.  The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .